Nephrology and Renal Diseases

In depth clinical trial expertise in renal disease

PPD has significant experience in the design, planning and execution of Phase I-IV full service global trials in renal diseases. Our nephrology team has in-depth insight into the scientific methodology, competitive research landscape and key regulatory drivers to move product development forward quickly.

PPD’s nephrology/renal disease global investigator network consists of nephrologists, critical care specialists, endocrinologists, internists and key opinion leaders, as well as a broad number of academic sites and dialysis centers which enable us to provide robust feasibility and consulting services across a wide spectrum of renal disease indications.

PPD recognizes that patients with renal disease often face the burden of living with other comorbidities that take a toll on their quality of life and life expectancy. We have developed a comprehensive team of medical experts across varying therapeutic areas including metabolic, cardiovascular, and autoimmune to ensure wholistic patient care. This integrated team of medical experts provide our clients with sound strategic guidance to drive efficient and effective clinical trials that address the challenges associated with renal diseases.

Explore the latest industry trends and clinical advancements from leading nephrology experts

0 +

Studies

0 +

Patients

0 +

Sites

Renal and nephrology clinical study experience

Our comprehensive renal and nephrology clinical study experience spans a broad range of indications including:

  • Chronic renal disease and end stage renal disease
  • Diabetic nephropathy
  • Hyperphosphatemia
  • Vasculitis (i.e., SLE)
  • Acute kidney injury
  • Anemia
  • Glomerulonephritis (i.e., IgA nephropathy and focal glomerulosclerosis)
  • Hyperoxaluria
  • Kidney transplantation
  • Polycystic kidney disease
  • Alport syndrome

Additionally, our team has experience working with pediatric and rare renal conditions, having conducted 27 rare renal disease studies over the past five years.

Advancing treatments for CKD and Rare Renal Disorders: Our experts weigh in
Experts address a high unmet need for advancing treatments for rare renal diseases